A randomized crossover trial of regional anticoagulation modalities for intermittent haemodialysis
Nephrology Dialysis Transplantation · 2025
DOI: 10.1093/ndt/gfae155 ↗Kurz gefasst
Klinische Studie (Phase II) in der Zeitschrift Nephrology Dialysis Transplantation, 2025. Verfasst von Stanislas Faguer und 8 weiteren Autor:innen. Beteiligte Einrichtung: Département de Néphrologie et Transplantation d'organes, French Intensive Care Renal Network, Centre Hospitalier Universitaire de Toulouse, Toulouse,…. Hauptthemen laut MEDLINE: Anticoagulants, Hemorrhage, Kidney Failure, Chronic, Renal Dialysis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: French Ministry of Health.
Abstract (Originalsprache)
Background
The optimal regional anticoagulation (RA) of dialysis filters in patients at risk of bleeding remains elusive. Inducing hypocalcaemia within the filter by using a calcium-free dialysate has emerged as an easy-to-use heparin-free RA, including in critically ill patients, but comparative studies are lacking.
Methods
We conducted a multicentre, randomized, crossover trial to compare the efficacy and tolerance of two RAs [heparin-coated membrane (HCM) and calcium-free dialysate (CFD) with calcium reinjection according to ionic dialysance] in patients requiring haemodialysis and at risk of bleeding. During the study period, each patient received two dialysis sessions (one with each RA in a randomly assigned order). The primary endpoint was the proportion of dialysis sessions completed (≥240 min).
Results
A total of 94 patients were included in the intention-to-treat analysis, including 16 critically ill patients (17.0%). Coagulation and inflammation parameters, as well as haemodynamic status at baseline, were balanced between groups. Premature coagulation of the filter occurred in 19 (20.9%) HCM sessions compared with 3 (3.2%) CFD sessions. In half of the sessions with premature termination, coagulation occurred before 180 min. The proportion of patients who completed the CFD session while failing to complete the HCM session (n = 17) was significantly higher than the proportion of patients who completed the HCM session while failing to complete the CFD session (n = 1; P < .001). Haemodynamic and metabolic tolerance were not different between groups.
Conclusions
In individuals at risk of bleeding, RA with CFD significantly reduced the incidence of premature dialysis termination compared with HCM without safety concerns.
Trial registration
ClinicalTrials.gov, NCT03842657.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Département de Néphrologie et Transplantation d'organes, French Intensive Care Renal Network, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.
- Université Paul Sabatier - Toulouse-3, Faculté de Santé, Toulouse, France.
- Institut National de la Santé et de la Recherche Médicale, UMR 1297, Institut des Maladies Métaboliques et Cardiovasculaires, Toulouse, France.
- Service de Néphrologie, Hôpital Lapeyronie, CHU de Montpellier, Montpellier, France.
- Unité de Soutien Méthodologique à la Recherche, Service d'Epidémiologie Clinique et Santé Publique, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.
- Service de Néphrologie-Dialyse-Aphérèses, Centre Hospitalier Universitaire de Nîmes, IDESP Université de Montpellier, Nîmes, France.
ORCID-Profile: Stanislas Faguer, Olivier Moranne
Förderung
- French Ministry of Health
Zitieren
APA
Faguer, S., Serre, J. E., Brusq, C., Bongard, V., Casemayou, A., Moranne, O., Pfirmann, P., Rafat, C., & Cointault, O. (2025). A randomized crossover trial of regional anticoagulation modalities for intermittent haemodialysis. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfae155
Vancouver
Faguer S, Serre JE, Brusq C, Bongard V, Casemayou A, Moranne O, et al. A randomized crossover trial of regional anticoagulation modalities for intermittent haemodialysis. Nephrology Dialysis Transplantation. 2025. doi:10.1093/ndt/gfae155
BibTeX
@article{Faguer2025,
author = {Faguer, Stanislas and Serre, Jean-Emmanuel and Brusq, Clara and Bongard, Vanina and Casemayou, Audrey and Moranne, Olivier and Pfirmann, Pierre and Rafat, Cédric and Cointault, Olivier},
title = {A randomized crossover trial of regional anticoagulation modalities for intermittent haemodialysis},
journal = {Nephrology Dialysis Transplantation},
year = {2025},
doi = {10.1093/ndt/gfae155}
}
EUVIMED